CD8A and neoplasm: The depletion of TANs delayed tumor growth and restored the antitumor CD8+ T cell responses, indicating that PD-L1+ TANs suppress tumor-specific CD8+ effector T cells expressing PD-1, through PD-L1/PD-1 signaling [29].